Full implementation of DAVA project to check fake drugs export

Image
Press Trust of India New Delhi
Last Updated : Dec 31 2015 | 5:23 PM IST
Full implementation of DAVA (Drug Authentication and Verification Application) project will help check export of spurious drugs from the country, the Commerce Ministry said today.
"When fully implemented (the DAVA project), the export of fake or spurious drug from the country will not be possible and in case it happens it would be easily traceable," it said in a statement.
The project has won the 2015 eASIA Award under Trade Facilitation category as announced by Asia Pacific Council for Trade Facilitation and Electronic Business (AFACT) in Tehran, it said.
"This project will contribute considerably in enhancing the brand image of our pharmaceutical exporters," it said.
DAVA project, launched on June 29, 2015, created an integrated platform for implementation of the track and trace system both for exports and domestic markets of drugs and pharmaceuticals.
"It is in the pilot stage and will be subsequently made mandatory for all pharmaceutical exports from India," it said.
The DAVA project also aims to cover all the drugs manufactured in India. Indian Pharmaceutical industry has about 250 large units and more than 8,000 small and medium scale units.
The project will provide simpler means to the consumer and regulatory agencies for establishing drug authentication and protect the India's brand image in international trade, the statement said.
In 2014-15, India's pharmaceutical exports grew by 2.63 per cent to USD 15.34 billion.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 31 2015 | 5:23 PM IST

Next Story